Marketing authorisation was given to the cannabis-based medicines Epidyolex and Sativex.[1][2]
Score by segment 0 to 10
- Possession · 25%1 → 1
- Personal cultivation · 25%1 → 1
- Punishment & enforcement · 20%3 → 3
- Sharing & gifting · 10%1 → 1
- Consumption · 10%1 → 1
- Legal access · 10%0 → 1+1
The bar shows the score after the change; the tick marks where it stood before. The scores after the change are Liechtenstein's current scores.
References
Checked. The date and the event were compared with a source that was read. The score before the change is an editorial estimate.